Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer

This multicentre phase II study evaluated the efficacy and safety of preoperative capecitabine plus oxaliplatin and radiotherapy (RT) in patients with locally advanced rectal cancer (T3/T4 rectal adenocarcinoma with or without nodal involvement). Treatment consisted of one cycle of XELOX (capecitabi...

Descripción completa

Detalles Bibliográficos
Autores principales: Koeberle, D, Burkhard, R, von Moos, R, Winterhalder, R, Hess, V, Heitzmann, F, Ruhstaller, T, Terraciano, L, Neuweiler, J, Bieri, G, Rust, C, Toepfer, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359632/
https://www.ncbi.nlm.nih.gov/pubmed/18349837
http://dx.doi.org/10.1038/sj.bjc.6604297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359632/
https://www.ncbi.nlm.nih.gov/pubmed/18349837
http://dx.doi.org/10.1038/sj.bjc.6604297

Ejemplares similares